Slovenian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

neoplasms/protease

Povezava se shrani v odložišče
Stran 1 iz 299 rezultatov

Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD This application relates to novel variant proaerolysin (PA) proteins and methods of their use to treat localized and metastatic prostate cancer. BACKGROUND One of every three cancers diagnosed in American males is of prostatic origin, making prostate cancer the most commonly diagnosed

Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD This application relates to novel variant proaerolysin (PA) proteins and methods of their use to treat localized and metastatic prostate cancer. BACKGROUND One of every three cancers diagnosed in American males is of prostatic origin, making prostate cancer the most commonly diagnosed

Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD This application relates to novel variant proaerolysin (PA) proteins and methods of their use to treat localized and metastatic prostate cancer. BACKGROUND One of every three cancers diagnosed in American males is of prostatic origin, making prostate cancer the most commonly diagnosed

Serine proteases as biomarkers for ovarian cancer

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION The described invention generally relates to ovarian cancer. BACKGROUND Ovarian Cancer Ovarian cancer ranks as the fifth most common cancer in women and has the highest mortality rate among gynecologic malignancies (Suh K S, Park S W, Castro A, Patel H, Blake P, Liang M, et

Anti-tumor protease preparations

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to an anti-tumor agent containing protease originating from microorganisms as an effective component, to an anti-tumor agent containing chemically modified protease originating from microorganisms as an effective component,

Identification of modulators of serine protease inhibitor Kazal and their use as anti-cancer and anti-viral agents

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND OF THE INVENTION 1. Field of Invention This invention relates to serine protease inhibitor Kazal (SPIK/SPINK/PSTI) and more specifically, its inhibitors and the use of inhibitors of SPIK as anti-cancer agents and anti-viral agents such as hepatitis B and C virus (HBV and HCV). 2.

Personalized protease assay to measure protease activity in neoplasms

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION This invention pertains to methods and composition that find use in diagnostic, prognostic and characterization of neoplasia samples based on the ability of a neoplasia sample to cleave a MTS molecule of the present invention. BACKGROUND OF THE INVENTION Introduction Cell

Nucleic acids that encode testes specific protease and detect DNA hypomethylated in cancer cells

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION The present invention provides Methyl- (or Mutant-) Differential Display (MDD) methods and nucleic acid probes for detecting mutations and/or the methylation patterns of nucleic acids. Genes are frequently not methylated in the cells where they are expressed but are methylated
BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates generally to the prostate and specifically to a novel complex of hK2 and PI-6 formed in the prostate, and methods of using the novel complex. 2. Description of the Prior Art Throughout this application, various references
BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates generally to the prostate and specifically to a novel complex of hK2 and PI-6 formed in the prostate, and methods of using the novel complex and its constituents. 2. Description of the Prior Art Throughout this application,

Protease K resistant arginine deiminase, its method of preparation and its use as an anti-neoplastic agent

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION The invention relates to an enzyme, arginine deiminase. In particular, it relates to a unique arginine deiminase isolated from mycoplasmas. More particularly, the invention is directed to a mycoplasmal proteinase K resistant arginine deiminase and to a method of preparing

Ricin-like toxin variants for treatment of cancer, viral or parasitic infections

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION The invention relates to proteins useful as therapeutics against cancer, viral infections, parasitic and fungal infections. The proteins contain A and B chains of a ricin-like toxin linked by a linker sequence that is specifically cleaved and activated by proteases specific to

Compositions and methods for inhibition of cancer invasion and angiogenesis

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION The present invention relates generally to the field of medicine, and relates specifically to angiogenesis and metastasis of cancer tissues. Specifically the invention relates to the use of antagonists of the serine integral membrane protease, dipeptidyl peptidase IV (DPPIV

Cancer cell migration and cancer cell invasion inhibitor

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
TECHNICAL FIELD The present invention relates to cancer cell migration and cancer cell invasion inhibitors. More specifically, the present invention relates to a PAR1 antibody inhibiting a cell migration activity and a cell invasion activity induced by MMP1 as well as a medicinal composition

Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
CROSS REFERENCE TO RELATED APPLICATION This application is a National Stage of International Application No. PCT/KR2011/009914 filed Dec. 21, 2011, claiming priority based on Korean Patent Application No. 10-2010-0132955 filed Dec. 23, 2010, the contents of all of which are incorporated herein by
Pridružite se naši
facebook strani

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

  • Deluje v 55 jezikih
  • Zeliščna zdravila, podprta z znanostjo
  • Prepoznavanje zelišč po sliki
  • Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
  • Preberite znanstvene publikacije, povezane z vašim iskanjem
  • Iščite zdravilna zelišča po njihovih učinkih
  • Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah

Google Play badgeApp Store badge